Qiu Guoqin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma (NCT06303583) | Qiu Guoqin | 2022-06-01 |
Track Qiu Guoqin automatically
Every clearance here is in the API, with alerts when new ones post.